Barclays Initiates Coverage on Anteris Technologies Global (NASDAQ:AVR)

Stock analysts at Barclays assumed coverage on shares of Anteris Technologies Global (NASDAQ:AVRGet Free Report) in a research note issued on Tuesday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $22.00 price target on the stock. Barclays‘s target price indicates a potential upside of 290.76% from the company’s previous close.

Anteris Technologies Global Price Performance

NASDAQ AVR opened at $5.63 on Tuesday. Anteris Technologies Global has a 52 week low of $5.10 and a 52 week high of $6.00.

About Anteris Technologies Global

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Recommended Stories

Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.